Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub‐Saharan Africa: a systematic review

K Kranzer, D Govindasamy, N Ford… - African Journal of …, 2012 - journals.lww.com
Introduction: Recent years have seen an increasing recognition of the need to improve access
and retention in care for people living with HIV/AIDS. This review aims to quantify patients …

Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review

K Kranzer, N Ford - Tropical Medicine & International Health, 2011 - Wiley Online Library
Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic
review - Kranzer - 2011 - Tropical Medicine & … Katharina KranzerKatharina Kranzer

[HTML][HTML] Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

SD Lawn, SV Brooks, K Kranzer, MP Nicol… - PLoS …, 2011 - journals.plos.org
Background The World Health Organization has endorsed the Xpert MTB/RIF assay for
investigation of patients suspected of having tuberculosis (TB). However, its utility for routine TB …

[HTML][HTML] Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa

K Kranzer, J Zeinecker, P Ginsberg, C Orrell… - PloS one, 2010 - journals.plos.org
Background Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme
reports typically focus on loss to follow-up and mortality among patients receiving ART. …

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

…, E Jaramillo, S Kik, K Kranzer… - European …, 2015 - Eur Respiratory Soc
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …

Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review

D Govindasamy, N Ford, K Kranzer - Aids, 2012 - journals.lww.com
Objective: To characterize patient and programmatic factors associated with retention in
care during the pre-antiretroviral therapy (ART) period and linkage to ART care. Design: …

Interventions to improve or facilitate linkage to or retention in pre‐ART (HIV) care and initiation of ART in low‐and middle‐income settings–a systematic review

…, RC Baggaley, N Ford, K Kranzer - Journal of the …, 2014 - Wiley Online Library
Introduction Several approaches have been taken to reduce pre‐antiretroviral therapy (ART)
losses between HIV testing and ART initiation in low‐ and middle‐income countries, but a …

[PDF][PDF] Pre-treatment loss to follow-up in tuberculosis patients in low-and lower-middle-income countries and high-burden countries: a systematic review and meta …

…, JR Glynn, EL Corbett, K Kranzer - Bulletin of the World …, 2013 - SciELO Public Health
Objective To assess the magnitude of loss to follow-up in smear- or culture-positive
tuberculosis patients before treatment initiation and outcomes among patients who were traced. …

Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study

J van Ingen, TA Kohl, K Kranzer, B Hasse… - The Lancet Infectious …, 2017 - thelancet.com
Background Since 2013, over 100 cases of Mycobacterium chimaera prosthetic valve
endocarditis and disseminated disease were notified in Europe and the USA, linked to …

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

SD Lawn, R Wood, KM De Cock, K Kranzer… - The Lancet infectious …, 2010 - thelancet.com
Antiretroviral therapy and isoniazid preventive therapy (IPT) are both effective interventions
to prevent HIV-associated tuberculosis, but work via different mechanisms. We propose that …